Skip to main content

Table 2 Results for system suitability

From: Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form

Sr. no.

Parameters

Results

Acceptance criteria

1

Peak area (6 replicate injections)

Area

 

1

5325966

2

5351414

3

5329388

4

5320723

5

5303219

6

5336522

Mean peak area

5327872

RSD, relative standard deviation

0.3%

RSD must be less than 2

2

Retention time

4.5 min

Must be more than 2 min